UroGen Pharma URGN Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
The official record: UroGen Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about UroGen Pharma's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is UroGen Pharma's enterprise value?
- UroGen Pharma (URGN) reported enterprise value of $962.43M in Q1 2026.
- How has UroGen Pharma's enterprise value changed year-over-year?
- UroGen Pharma's enterprise value increased by 80.9% year-over-year, from $532.13M to $962.43M.
- What is the long-term trend for UroGen Pharma's enterprise value?
- Over 5 years (2020 to 2025), UroGen Pharma's enterprise value has grown at a 25.8% compound annual growth rate (CAGR), from $353.85M to $1.12B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.